AHA says Anthem-Cigna merger would boost Blue Cross dominance

In a letter to the Department of Justice, the American Hospital Association said Anthem’s proposed acquisition of Cigna would reduce the ability of other health insurers to compete with Blue Cross Blue Shield plans.

Advertisement

In its letter, the AHA raised concerns about the anticompetitive potential of the Anthem-Cigna merger, including Anthem’s affiliation with BCBS.

“The acquisition threatens to both reinforce existing barriers to entry and raise new ones, further entrench dominant Blues plans, and exacerbate conditions conducive to abuse of market or monopoly power,” wrote Melinda Reid Hatton, AHA senior vice president and general counsel.

Collectively, Anthem and other BCBS plans cover 105 million lives, according to the AHA. The addition of Cigna adds 14.7 million lives, representing a 14 percent increase in the lives covered by BCBS plans nationwide.

More articles on payer issues:

CMS finalizes changes to ACA marketplace: 6 things to know
Aetna CEO reverses opinion, now ‘likes’ ACA exchanges
Fitch: Blue Cross hit hard by ACA losses

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.